Navigation Links
Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
Date:9/7/2010

SAN DIEGO, Sept. 7 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company will present a corporate overview at the following investment conferences:


  • Morgan Stanley Global Healthcare ConferenceDate:  Tuesday, September 14, 2010 Time:  10:55am Eastern Time (7:55am Pacific Time)Place:  Grand Hyatt Hotel in New York City Speaker:  Ted Schroeder, President & CEO


  • Stifel Nicolaus Healthcare Conference 2010Date:  Thursday, September 16, 2010Time:  8:00am Eastern Time (5:00am Pacific Time)Place:  Four Seasons Hotel in BostonSpeaker:  Ted Schroeder, President & CEO


  • UBS Global Life Sciences ConferenceDate:  Wednesday, September 22, 2010Time:  10:00am Eastern Time (7:00am Pacific Time)Place:  Grand Hyatt Hotel in New York CitySpeaker:  William R. LaRue, SVP & CFO


  • JMP Securities Healthcare ConferenceDate:  Monday, September 27, 2010Time:  10:00am Eastern Time (7:00am Pacific Time)Place:  The New York Palace Hotel in New York CitySpeaker:  Ted Schroeder, President & CEOEach presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals' website at www.cadencepharm.com on the Investor Relations page.  A replay of each webcast will available approximately three hours after the live webcast concludes and will remain available for 30 days.

    About Cadence Pharmaceuticals, Inc.Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting. For more information about Cadence, visit www.cadencepharm.com. Contacts:

    William R. LaRue

    SVP, CFOCadence Pharmaceuticals, Inc.

    858-436-1400
    '/>"/>


  • SOURCE Cadence Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
    2. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
    3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
    4. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
    5. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
    6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
    7. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
    8. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
    9. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
    10. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
    11. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/10/2017)... 2017 Radiology has become the number one ... also spiraled to the number one ranking as a ... ever before as the most complete and reliable method ... lower back pain an MRI may confirm a suspected ... resulting in entirely different treatment protocols.  In these circumstances, ...
    (Date:5/9/2017)... 2017  Semler Scientific, Inc. (OTCQB: SMLR), an ... improve the clinical effectiveness and efficiency of healthcare ... quarter ended March 31, 2017. ... to identify when preventive care options are appropriate, ... heart attacks or strokes occur," said Doug ...
    (Date:5/6/2017)... May 5, 2017  Hill-Rom Holdings, Inc. (NYSE: HRC), ... 100,000 square feet to its Welch Allyn campus. ... commitment to bring more than 100 new jobs to ... Allyn has maintained a significant presence for more than ... new positions, a large portion of which will be ...
    Breaking Medicine Technology:
    (Date:5/26/2017)... , ... May 26, 2017 , ... On May 24, ... which narrowly passed the U.S. House on May 4, would result in 23 million ... under continued implementation of the 2010 Patient Protection and Affordable Care Act (ACA). ...
    (Date:5/26/2017)... ... May 26, 2017 , ... Rob Lowe acts as host and helps educate ... is on hiking in American. Viewers can reconnect with America as it explores some ... , Many consumers have looked for an inventive new place for a family vacation, ...
    (Date:5/26/2017)... ... 26, 2017 , ... Centennial-based BluSky Restoration Contractors announced that ... Annual Clays for Kids fundraiser, to be held Friday, Sept. 22, at Kiowa ... part of BluSky’s partnership with The Adoption Exchange, BluSky will also share sponsorship ...
    (Date:5/24/2017)... , ... May 24, 2017 , ... ... Medical Center CEO Mary Ellen, hospital employees, and town officials to celebrate the ... The facility was developed by Rendina as part of its ongoing relationship with ...
    (Date:5/24/2017)... Diego, California (PRWEB) , ... May 24, 2017 ... ... care through innovative medical image management and interpretation, has received U.S. Food and ... , Nucleus.io is a web-based, scalable and secure cloud platform for medical ...
    Breaking Medicine News(10 mins):